Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript
Thank you. Good morning, everyone. My name is Gena Wang. I'm (inaudible) biotech analyst at the Barclays. Welcome to our seventh gene editing, gene therapy summit. It is really great to have this happened again. I wanted to take this opportunity to thank all the investors companies, and also especially our event team and the corporate access team who made this event possible. With that, I would like to introduce our next presenting company, Beam Therapeutics. With us today, we have John Evans, Chief Executive Officer. John, thank you very much for giving us this opportunity.
Thank you for having me.
Yes. So maybe before we dive into the specific questions, do you want to give a quick overview.
Sure. Yes. So Beam
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
